본문으로 건너뛰기
← 뒤로

Letter to the editor: "Chatbots for breast cancer education: a systematic review and meta-analysis".

메타분석 1/5 보강
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2026 Vol.34(4)
Retraction 확인
출처

Xie Y, Wang W, Ning L

📝 환자 설명용 한 줄

[PURPOSE] This correspondence serves to critically evaluate the meta-analysis by Lin et al.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 연구 설계 meta-analysis

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Xie Y, Wang W, Ning L (2026). Letter to the editor: "Chatbots for breast cancer education: a systematic review and meta-analysis".. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 34(4). https://doi.org/10.1007/s00520-026-10576-3
MLA Xie Y, et al.. "Letter to the editor: "Chatbots for breast cancer education: a systematic review and meta-analysis".." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, vol. 34, no. 4, 2026.
PMID 41870634

Abstract

[PURPOSE] This correspondence serves to critically evaluate the meta-analysis by Lin et al. regarding chatbot-led breast cancer education, focusing on specific methodological weaknesses that may undermine its core findings.

[METHODS] We performed a rigorous appraisal of the original study's methodology, specifically scrutinizing their data synthesis process, the inclusion criteria for trials, and the conceptual clarity of the outcome measures used to gauge chatbot performance.

[RESULTS] Our analysis revealed three primary concerns: (1) the reliance on a mere six studies raises concerns about the generalizability of the results; (2) a major unit-of-analysis error occurred where multiple intervention arms from a single study were incorrectly "double-counted" as independent data points; and (3) there was a clear conceptual conflation between "usability" and "educational efficacy, leading to ambiguous interpretations of the chatbots' actual impact.

[CONCLUSION] Given these identified flaws, the evidence presented in the meta-analysis remains inconclusive and should be approached with skepticism. To advance the field, we urge the development of larger-scale randomized controlled trials and the consistent application of validated instruments, such as the System Usability Scale (SUS), to ensure more reliable data in digital health research.

MeSH Terms

Female; Humans; Breast Neoplasms; Generative Artificial Intelligence; Meta-Analysis as Topic; Patient Education as Topic; Systematic Reviews as Topic

같은 제1저자의 인용 많은 논문 (5)